AbbVie steps up for Glenmark's multispecific
The deal for ISB 2001 is worth $700m up front.
The deal for ISB 2001 is worth $700m up front.
The Tang Capital Partners vehicle has already acquired IGM, Elevation and Kronos.
“We need all the capital we can get our hands on," the company states.
But the former is paying a fraction of what Merck shelled out for raludotatug.